Inexpensive Drug Costing Less Than Three Dollars May Minimize Damage from Heart Attack
Collaborative Study by Spain and Icahn School of Medicine at Mount Sinai Shows Potential Benefits of Administering Beta-Blocker Medication to Heart Attack Patients in Ambulance
Early treatment of heart attack patients with an inexpensive beta-blocker drug called metoprolol, while in transit to the hospital, can significantly reduce damage to the heart during a myocardial infarction, according to clinical trial study results published Oct. 1 in the journal Circulation. The study was a collaboration between Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Spain and Icahn School of Medicine at Mount Sinai in New York.